| Ana Paula Arruda, PhD * |
Liver Metabolism & Organ Cross-Talk |
ER stress in metabolic liver disease |
| Jody L. Baron, MD, PhD |
Liver Injury & Immunology |
Hepatic immune responses in viral hepatitis and liver cancer |
| James Bayrer, MD, PhD |
Liver Metabolism & Organ Cross-Talk |
Gut-liver axis in metabolic control |
| Michael Bokoch, MD, PhD |
Liver Regeneration & Clinical Transplantation |
Interventions to improve outcomes of liver transplant surgery (*Current PF) |
| Laura N. Bull, PhD |
Liver Injury & Immunology |
Hereditary cholestatic disorders |
| Tammy Chang, MD, PhD |
Liver Injury & Immunology |
Cell-matrix interactions; tissue engineering |
| Jennifer Chen, MD |
Liver Injury & Immunology |
Mechanisms and treatment of hepatic fibrosis |
| Xu Chen, PhD |
Liver Regeneration & Clinical Transplantation |
Metastatic malignancy to the liver |
| Stewart Cooper, MD |
Liver Injury & Immunology |
Hepatic immunology in viral hepatitis and liver cancer |
| M. Almira Correia, PhD |
Liver Regeneration & Clinical Transplantation |
Cytochrome P450 regulation; ER stress |
| Giuseppe (Joe) Cullaro, MD |
Liver Regeneration & Clinical Transplantation |
Chronic kidney disease in patients with cirrhosis |
| Markus Delling, PhD |
Liver Regeneration & Clinical Transplantation |
Primary cilia in liver and other organs |
| Jin Ge, MD, MBA |
Liver Injury and Immunology |
Chronic liver disease, EHR-based investigation |
| Andrei Goga, MD, PhD |
Liver Regeneration & Clinical Transplantation |
Mechanisms of hepatocarcinogenesis |
| Emily Goldberg, PhD |
Liver Metabolism & Organ Cross-Talk |
Ketogenesis in aging and immune consequences |
| Bilal Hameed, MD |
Liver Regeneration & Clinical Transplantation |
Liver transplantation; fatty liver disease; drug and surgical interventions |
| Roarke Kamber, PhD * |
Liver Injury and Immunology |
Kupffer cell-mediated clearance |
| Robin Kate Kelley, MD |
Liver Regeneration & Clinical Transplantation |
Hepatobiliary malignancies |
| Mandana Khalili, MD, MAS |
Liver Injury & Immunology |
Viral hepatitis, metabolism, fatty liver disease |
| Jennifer Lai, MD |
Liver Regeneration & Clinical Transplantation |
Frailty and outcomes in liver transplantation |
| Chris Lau, PhD |
Liver Regeneration & Clinical Transplantation |
Sex differences in hepatocellular cancer |
| James Lee, MD |
Liver Injury & Immunology |
Immune mechanisms of checkpoint inhibitor escape in liver metastasis |
| Michael Li, MD, MPH * |
Liver Injury & Immunology |
Immunotherapy for liver disease: response and toxicity |
| Jacquelyn J. Maher, MD |
Liver Metabolism & Organ Cross-Talk |
Fatty liver disease; mechanisms of liver cell death |
| Ajay Maker, MD |
Liver Injury & Immunology |
Tumor immunology; hepatic metastasis |
| Aras Mattis, MD, PhD |
Liver Metabolism & Organ Cross-Talk |
Mechanism of steatohepatitis |
| Marisa Medina, PhD |
Liver Metabolism & Organ Cross-Talk |
Cholesterol metabolism and metabolic liver disease; iPSC modeling |
| Ari Molofsky, MD, PhD |
Liver Injury & Immunology |
Immune regulation of liver fibrosis |
| Alexander Monto, MD |
Liver Injury & Immunology |
Viral hepatitis and liver cancer |
| David Moore, PhD |
Liver Regeneration & Clinical Transplantation |
Nuclear receptors in metabolism and carcinogenesis |
| Anders Naar, PhD |
Liver Metabolism & Organ Cross-Talk |
MicroRNAs in the regulation of hepatic metabolism |
| Amar Nijagal, MD |
Liver Injury & Immunology |
Neonatal hepatic inflammation in biliary atresia and hepatoblastoma |
| Joni Nikkanen, PhD * |
Liver Injury & Immunology |
Neurobiology,metabolism,sex differences,neuroendocrinology,innate immunity and infectious diseases |
| Patrick O'Farrell, PhD |
Liver Regeneration & Clinical Transplantation |
Mitochondrial DNA integrity and mutations with age |
| Michael Ohliger, MD, PhD |
Liver Injury & Immunology |
Novel imaging modalitites for liver disease |
| James Olzmann, PhD |
Liver Metabolism & Organ Cross-Talk |
Lipid droplet biology; lipotoxicity |
| Melanie Ott, MD, PhD |
Liver Injury & Immunology |
HBV, HCV virology and pathogenesis |
| Emily Perito, MD, MAS |
Liver Regeneration & Clinical Transplantation |
Liver transplantation in children; NAFLD in children |
| Jennifer Price, MD |
Liver Injury & Immunology |
Liver diseae in patients living with HIV |
| Vijay Ramani, PhD |
Liver Regenration & Clinical Transplantation |
Impact of polyploidy on hepatocyte genome architecture |
| Garertt R. Roll, MD, FACS * |
Liver Regeneration & Clinical Transplantation |
Cell therapy with hepatocytes-like cells derived from stem cells |
| Philip Rosenthal, MD |
Liver Injury & Immunology |
Pediatric liver diseases and transplantation |
| Jessica Rubin, MD, MPH |
Liver Injury and Immunology |
Pain management in cirrhosis patients |
| Carolyn Sangokoya, MD, PhD * |
Liver Regeneration & Clinical Transplantation |
Cellular iron regulation in liver |
| Monika Sarkar, MD |
Liver Metabolism & Organ Cross-Talk |
Sex hormone influences on fatty liver disease |
| Andreas Stahl, PhD |
Liver Metabolism & Organ Cross-Talk |
Liver-adipose axis; metabolic influences on hepatocarcinogenesis |
| Peter G. Stock, MD, PhD |
Liver Regeneration & Clinical Transplantation |
Solid organ transplants in HIV-infected patients |
| Michele Tana, MD |
Liver Injury & Immunology |
Pathogenesis of autoimmune liver diseases; health disparities in AIH |
| Sharad Wadhwani, MD, MPH |
Liver Regeneration & Clinical Transplantation |
Social determinants of health and transplant outcomes in children |
| Bruce Wang, MD |
Liver Regeneration & Clinical Transplantation |
Factors determining hepatocyte heterogeneity |
| Jen-Chywan Wang, PhD |
Liver Metabolism & Organ Cross-Talk |
Glucocorticoid regulation of liver metabolism |
| Holger Willenbring, MD, PhD |
Liver Regeneration & Clinical Transplantation |
Liver regeneration and carcinogenesis; gene therapy; metabolic liver disease |
| Allison Xu, PhD |
Liver Metabolism & Organ Cross-Talk |
Neural control of hepatic steatosis |
